partnership Venus Remedies x Infex to Combat Antimicrobial Resistance in India Congratulations, Venusians. We have yet again marked another day on the calendar with gold! Venus Remedies Ltd. is delighted to announce a significant partnership with UK-based anti-infective drug development company, Infex Therapeutics. The alliance aims to tackle drug-resistant Gram-negative bacterial infections via MET-X, an innovative metallo-beta-lactamase (MBL) inhibitor. Under this
Transformation Featured Global Critical Care Introduces E-Detailing via Tablets for Improved Healthcare Professional Engagement Venus' Global Critical Care has gone digital with the introduction of e-detailing via tablets! After a successful beta phase, e-detailing has now officially been implemented from 1st April 2023. This new development will be an instrumental tool in helping to improve patient care and drive company growth. E-detailing is
